CHU Sainte-Justine Research Centre Archives - Pediatric Research Foundation
Make a donation

Project context New clinical trial combining chemotherapy and targeted therapies (MEK inhibitor mirdametinib) from diagnosis onwards. Low-grade paediatric gliomas are the most common brain tumours and usually require intravenous chemotherapy. Unfortunately, most tumours progress and other therapeutic avenues must be explored. Thanks to an initial study (TRAM-01) supported by the Paediatric Research Foundation in 2017, […]

Principal investigator

  • Dr. Sébastien Perreault Pediatric neurologist and clinician-researcher CHU Sainte-Justine

Oncologie et neurodéveloppement

The World Health Organization has included global child health in its priorities for action to achieve marked and sustained improvements in the health of the world’s population by 2030.

Principal investigator

Perinatal, neonatal and obstetrics

Berger’s disease, also known as IgA nephropathy, is an autoimmune disease that damages a person’s kidneys. It affects between 2 and 10 out of every 100,000 people each year and although it often occurs in young adults, it may appear during childhood.

Principal investigator

  • Dr. Alexandra Cambier, Assistant Professor, Pediatric Nephrology, CHU Sainte-Justine

Cancer Inflammations and infections

Accountability

-

In October 2020, the Association des pédiatres du Québec (APQ) sounded the alarm about the current and future impacts of the COVID-19 pandemic on the mental health of children and adolescents. At CHU Sainte-Justine, the number of cases has doubled over the past year.

Principal investigator

  • Dr. Nicholas Chadi, pediatrician and clinical scientist specializing in adolescent medicine with degrees from McGill University, Université de Montréal, University of Toronto and Harvard University

Metabolic and cardiovascular health